Skip to main content

Table 2 Characteristics of trusts participating in interviews vs. all trial trusts

From: How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

 

Interview group

Trial population

All trusts in trial

 

MLVA

Ribotyping

MLVA

Ribotyping

 

Number Trusts Interviewed

5

6

NA

NA

NA

Hospital isolation facilities

     

Average bed size

1,056

977

922

912

902

Single rooms with en-suite (% total beds)

10%

10%

14%

13%

12%

Single rooms without en-suite (% total beds)

10%

6%

10%

7%

5%

Average typing test requests over 12 months

     

Test requests (mean number/trust)

56.0

61.5

66.8

58.6

50.4

All post 48 hr C difficile cases reported over 12 months

  

814

868

1,682